These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32029960)

  • 21. Association between PK/PD-involved gene polymorphisms and carbamazepine-individualized therapy.
    Ma CL; Jiao Z; Wu XY; Hong Z; Wu ZY; Zhong MK
    Pharmacogenomics; 2015; 16(13):1499-512. PubMed ID: 26314341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic polymorphisms of microsomal epoxide hydrolase and UDP-glucuronosyltransferase (UGT) and its effects on plasma carbamazepine levels and metabolic ratio in persons with epilepsy of South India: A cross-sectional genetic association study.
    Venkatraman S; Ramasamy K; Nair PP
    Indian J Pharmacol; 2023; 55(3):149-154. PubMed ID: 37555408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationships between carbamazepine-diol, carbamazepine-epoxide, and carbamazepine total and free steady-state concentrations in epileptic patients: the influence of age, sex, and comedication.
    Svinarov DA; Pippenger CE
    Ther Drug Monit; 1996 Dec; 18(6):660-5. PubMed ID: 8946662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Tacrolimus Intra-Patient Variability during 6-12 Months after Kidney Transplantation between CYP3A5 Expressers and Nonexpressers.
    Nuchjumroon A; Vadcharavivad S; Singhan W; Poosoonthornsri M; Chancharoenthana W; Udomkarnjananun S; Townamchai N; Avihingsanon Y; Praditpornsilpa K; Eiam-Ong S
    J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of CYP3A5*3 genetic polymorphisms on the pharmacokinetics of perampanel in Chinese pediatric patients with epilepsy.
    Zhao T; Feng JR; Zhang HL; Yu J; Feng J; Sun KF; Yu LH; Sun Y; Li HJ
    Pharmacogenet Genomics; 2024 Aug; 34(6):184-190. PubMed ID: 38728170
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Miyata-Nozaka Y; Tan HJ; Wong SW; Raymond AA; Omar H; Zain SM
    Int J Clin Pharmacol Ther; 2021 Jan; 59(1):8-16. PubMed ID: 33026315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lower tacrolimus daily dose requirements and acute rejection rates in the CYP3A5 nonexpressers than expressers.
    Tang HL; Xie HG; Yao Y; Hu YF
    Pharmacogenet Genomics; 2011 Nov; 21(11):713-20. PubMed ID: 21886016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients.
    Seo T; Ishitsu T; Ueda N; Nakada N; Yurube K; Ueda K; Nakagawa K
    Pharmacogenomics; 2006 Jun; 7(4):551-61. PubMed ID: 16753003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of CYP3A5 and MDR-1 gene polymorphisms on the dose and level of tacrolimus among living-donor liver transplanted patients: single center experience.
    Fathy M; Kamal M; Mohy A; Nabil A
    Biomarkers; 2016; 21(4):335-41. PubMed ID: 26856709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association Between Tacrolimus Pharmacokinetics and Cytochrome P450 3A5 and Multidrug Resistance Protein 1 Exon 21 Polymorphisms.
    Soda M; Fujitani M; Michiuchi R; Shibayama A; Kanamori K; Yoshikuni S; Ohno Y; Tsuchiya T; Suzuki A; Horie K; Deguchi T; Itoh Y; Kitaichi K
    Transplant Proc; 2017; 49(6):1492-1498. PubMed ID: 28736028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization.
    Hung CC; Chang WL; Ho JL; Tai JJ; Hsieh TJ; Huang HC; Hsieh YW; Liou HH
    Pharmacogenomics; 2012 Jan; 13(2):159-69. PubMed ID: 22188362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of EPHX1 and CYP3A4*22 genetic polymorphisms on carbamazepine metabolism and drug response among Tunisian epileptic patients.
    Chbili C; Fathallah N; Laouani A; Nouira M; Hassine A; Ben Amor S; Ben Ammou S; Ben Salem C; Saguem S
    J Neurogenet; 2016 Mar; 30(1):16-21. PubMed ID: 27276192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytochrome P450 3A5 genotype is associated with verapamil response in healthy subjects.
    Jin Y; Wang YH; Miao J; Li L; Kovacs RJ; Marunde R; Hamman MA; Philips S; Hilligoss J; Hall SD
    Clin Pharmacol Ther; 2007 Nov; 82(5):579-85. PubMed ID: 17443134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of
    Dhivya E; Kesavan R; Pradeep NP
    Drug Metab Pers Ther; 2024 Mar; 39(1):27-34. PubMed ID: 38507296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors influencing plasma concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic children and adults.
    Lanchote VL; Bonato PS; Campos GM; Rodrigues I
    Ther Drug Monit; 1995 Feb; 17(1):47-52. PubMed ID: 7725376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of carbamazepine on plasma concentrations of valproic acid and its toxic metabolite in epileptic patients].
    Chen ZJ; Wang XD; Zhou LM; Fang ZY; Wang HS; Li JL; Zhou JQ; Huang HB; Huang M
    Yao Xue Xue Bao; 2014 Apr; 49(4):530-4. PubMed ID: 24974473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of CYP3A5 Genetic Polymorphism on Long-Term Renal Function in Chinese Kidney Transplant Recipients Using Limited Sampling Strategy and Abbreviated Area Under the Curve for Tacrolimus Monitoring.
    Cheung CY; Chan KM; Wong YT; Chak WL; Bekers O; van Hooff JP
    Prog Transplant; 2020 Sep; 30(3):249-253. PubMed ID: 32552577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tacrolimus Dose Optimization Strategy for Refractory Ulcerative Colitis Based on the Cytochrome P450 3A5 Polymorphism Prediction Using Trough Concentration after 24 Hours.
    Onodera M; Endo K; Naito T; Moroi R; Kuroha M; Kanazawa Y; Kimura T; Shiga H; Kakuta Y; Negoro K; Kinouchi Y; Shimosegawa T
    Digestion; 2018; 97(1):90-96. PubMed ID: 29393157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Individualization of tacrolimus dosage basing on cytochrome P450 3A5 polymorphism--a prospective, randomized, controlled study.
    Chen SY; Li JL; Meng FH; Wang XD; Liu T; Li J; Liu LS; Fu Q; Huang M; Wang CX
    Clin Transplant; 2013; 27(3):E272-81. PubMed ID: 23432535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of ABCB1 polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy.
    Meng H; Guo G; Ren J; Zhou H; Ge Y; Guo Y
    Epilepsy Behav; 2011 May; 21(1):27-30. PubMed ID: 21493161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.